Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867494 | 0.86 | MLYCD (0.38) | PROKR1MLYCD | |
| SCHEMBL29581703 | 0.82 | MLYCD (0.42) | PROKR1MLYCD | |
| SCHEMBL12672262 | 0.82 | MLYCD (0.42) | PROKR1MLYCD | |
| SCHEMBL5775191 | 0.81 | MLYCD (0.41) | MLYCD | |
| SCHEMBL2145070 | 0.81 | KCNK3 (0.46) | PROKR1MLYCD | |
| SCHEMBL305997 | 0.81 | CYP11B1 (0.43) | PROKR1MLYCD | |
| SCHEMBL1886467 | 0.81 | MLYCD (0.44) | MLYCD | |
| SCHEMBL14222120 | 0.81 | MLYCD (0.41) | MLYCD | |
| SCHEMBL305494 | 0.81 | GABRP (0.54) | MLYCD | |
| SCHEMBL31191229 | 0.81 | CYP11B1 (0.43) | PROKR1MLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1612204-A1 | HYDRAZONE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | APP, PRNP, HTT | PROKR1 2391/4885MLYCD 3764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.